ZENAS BIOPHARMA
Live / Applied — Statement of use — processing complete, to examiner (as of 24 Nov 2025)
What this means for you
Not registered yet, but its 09 Nov 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97116161
- Mark type
- Stylized text
- Filed
- 09 Nov 2021
- Published for opposition
- 27 Sept 2022
- Attorney of record
- Karen Won
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations in the nature of auto-immune and immune-based therapies for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of auto-immune and immune-based diseases
Owner
- Zenas BioPharma (USA) LLC, Waltham, MA, US
- Zenas BioPharma (USA) LLC, Waltham, MA, US
Prosecution history
- 24 Nov 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Nov 2025 — USE AMENDMENT FILED
- 23 Nov 2025 — TEAS STATEMENT OF USE RECEIVED
- 02 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Oct 2025 — SOU EXTENSION 5 GRANTED
- 15 May 2025 — SOU EXTENSION 5 FILED
- 01 Oct 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Feb 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 03 Feb 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Dec 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 11 Dec 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 11 Dec 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Dec 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED